Dexamethasone and Etoricoxib for Pain Prevention Following Periodontal Surgery
NCT ID: NCT00970112
Last Updated: 2010-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
20 participants
INTERVENTIONAL
2008-11-30
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dexketoprofen and Etoricoxib in Patients Undergoing Hip Arthroplasty
NCT02568735
Efficacy and Safety of IV Diclofenac (DIV075V)for Pain After Elective Orthopedic Surgery
NCT00507026
Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Hip Arthroscopy
NCT04610398
Dexamethasone and Pain Following Total Knee Arthroplasty
NCT02271698
Dexamethasone Vs. Dexmedetomidine for ESPB in Pain Management After Knee Arthroplasty
NCT06470100
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Placebo 1 hour before surgery
Open Flap Debridement
Open flap debridement - access flap + scaling and root planning
Etoricoxib
Etoricoxib 1 hour before surgery
Open Flap Debridement
Open flap debridement - access flap + scaling and root planning
Dexamethaone
Dexamethasone 1 hour before surgery
Open Flap Debridement
Open flap debridement - access flap + scaling and root planning
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Open Flap Debridement
Open flap debridement - access flap + scaling and root planning
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Diabetes mellitus
* Heart diseases
* Allergic to components of the medications
* Risk of endocarditis
20 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Estadual de Ponta Grossa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
UEPG
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
João Paulo Steffens, MSc Student
Role: PRINCIPAL_INVESTIGATOR
UEPG
Fábio André Santos, PhD
Role: STUDY_DIRECTOR
UEPG
Gibson Luiz Pilatti, PhD
Role: STUDY_CHAIR
UEPG
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UEPG
Ponta Grossa, Paraná, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
51/2008
Identifier Type: -
Identifier Source: secondary_id
08169/08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.